ReachMD

Dr. Emmanuel E. Baetge is the senior vice president and chief scientific officer of ViaCyte. He joined ViaCyte(Cythera/Novocell) as chief scientific officer in 2001 to head its then emerging human embryonic stem cell project, which has grown into a major program in stem cell-derived pancreatic islets for diabetes.

Prior to ViaCyte, Dr. Baetge held the position of Chief Scientific Officer at Modex Therapeutics Ltd from 1997-2001 in Lausanne, Switzerland, which developed one of the first autologous adult stem cell products for the treatment of chronic skin ulcers. Before Modex, Dr. Baetge held management positions at CytoTherapeutics, Inc. from 1992-1997 and at Bristol-Myers Squibb from 1987-1992.

He holds a PhD in molecular neurobiology from Cornell University and completed postdoctoral work at both Cornell University and the Howard Hughes Medical Institute at University of Washington. Dr. Baetge has published extensively in the field of cell therapy and has produced a number of cell technology patents.